Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Luye Medical Commits $300 Million to Chongqing Hospital Venture
  Singlera Genomics Raises $20 Million in Series A Round Led by Lilly Asia
  Liaison Interactive Invests $20 Million in Beijing's Dehaier Medical
  Week in Review: China Group to Build $1.5 Billion Life Science Complex in South San Francisco
  Berry Genomics And BioNano Genomics Partner for Next-Gen Genome Mapping
  BeiGene OK'd to Test PARP Inhibitor in China
  Huapont Life Sciences Invests $6 Million in San Diego's Histogen
  Ambrx to Start US Clinical Trials of HER2 Cancer Drug
  Ark Bio of Shanghai Starts Phase II Trial of Novel RSV Treatment
  China Sun Pharma Invests in Glucovation, a Glucose Monitoring Company
 
Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors